Itch-Free State in Patients With Atopic Dermatitis Treated With Ruxolitinib Cream: Pooled Analysis From Two Randomized Phase 3 Studies

Authors

Andrew Blauvelt, Oregon Medical Research Center, Portland, OR, USA. Electronic address: ablauvelt@oregonmedicalresearch.com.
Jacek C. Szepietowski, Department of Dermatology, Venereology, and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Kim Papp, K. Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada.
Eric L. Simpson, Oregon Health & Science University, Portland, OR, USA.
Jonathan I. Silverberg, George Washington University, Washington, DC, USA.
Brian S. Kim, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Shawn G. Kwatra, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Michael E. Kuligowski, Incyte Corporation, Wilmington, DE, USA.
May E. Venturanza, Incyte Corporation, Wilmington, DE, USA.
Shaoceng Wei, Incyte Corporation, Wilmington, DE, USA.
Leon Kircik, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Document Type

Journal Article

Publication Date

9-13-2022

Journal

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2022.09.010

Keywords

Janus kinase; atopic dermatitis; itch; ruxolitinib; topical

APA Citation

Blauvelt, Andrew; Szepietowski, Jacek C.; Papp, Kim; Simpson, Eric L.; Silverberg, Jonathan I.; Kim, Brian S.; Kwatra, Shawn G.; Kuligowski, Michael E.; Venturanza, May E.; Wei, Shaoceng; and Kircik, Leon, "Itch-Free State in Patients With Atopic Dermatitis Treated With Ruxolitinib Cream: Pooled Analysis From Two Randomized Phase 3 Studies" (2022). GW Authored Works. Paper 1631.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/1631

Department

Dermatology